MENU

ITRM Iterum Therapeutics plc Forecast, Technical & Fundamental Analysis

an operator, which engages in the healthcare industry focusing on biotechnology business

Industry Biotechnology
View a ticker or compare two or three
Ad is loading...
A.I. Advisor
published Earnings

ITRM is expected to report earnings to fall 18.75% to -19 cents per share on March 31

Iterum Therapeutics plc ITRM Stock Earnings Reports
Q4'24
Est.
$-0.19
Q3'24
Missed
by $0.06
Q2'24
Beat
by $0.15
Q1'24
Beat
by $0.33
Q4'23
Beat
by $0.11
The last earnings report on November 14 showed earnings per share of -23 cents, missing the estimate of -17 cents. With 729.21K shares outstanding, the current market capitalization sits at 50.35M.
A.I. Advisor
published General Information

General Information

an operator, which engages in the healthcare industry focusing on biotechnology business

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Fitzwilliam Court
Phone
+353 16694820
Employees
14
Web
https://www.iterumtx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ITRM and Stocks

Correlation & Price change

A.I.dvisor tells us that ITRM and UBX have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ITRM and UBX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITRM
1D Price
Change %
ITRM100%
-2.14%
UBX - ITRM
24%
Poorly correlated
-5.56%
PHGE - ITRM
22%
Poorly correlated
-1.79%
ANAB - ITRM
22%
Poorly correlated
-3.96%
CRDF - ITRM
21%
Poorly correlated
+32.75%
FENC - ITRM
21%
Poorly correlated
+2.02%
More